Medicare’s New Drug Spending Cap Will Likely Help Few Seniors
Many With High Drug Costs Have Supplemental Coverage and Won’t Reach the $2,000 Out-of-Pocket Cap, a New LDI Study Finds
Search Results
Health Insurance from Employers Not Threatened—Yet—by Gene Therapy Costs
Rising Premiums on Stop-loss Insurance for Self-Insured Employer Plans Present a Risk
Medicare’s New Price-Setting Powers Are Historic But Could Harm Innovation, An LDI Fellow Warns
How The New Law Could Weaken The Part D Drug Program